Cargando…
Identification of a robust non-coding RNA signature in diagnosing autism spectrum disorder by cross-validation of microarray data from peripheral blood samples
Novel molecular signatures are needed to improve the early and accurate diagnosis of autism spectrum disorder (ASD), and indicate physicians to provide timely intervention. This study aimed to identify a robust blood non-coding RNA (ncRNA) signature in diagnosing ASD. One hundred eighty six blood sa...
Autores principales: | Cheng, Wei, Zhou, Shanhu, Zhou, Jinxia, Wang, Xijia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220435/ https://www.ncbi.nlm.nih.gov/pubmed/32176083 http://dx.doi.org/10.1097/MD.0000000000019484 |
Ejemplares similares
-
Development and validation of a novel and robust blood small nuclear RNA signature in diagnosing autism spectrum disorder
por: Zhou, Jinxia, et al.
Publicado: (2019) -
Spectrum of pediatric tumors diagnosed by fine-needle aspiration cytology
por: Shirian, Sadegh, et al.
Publicado: (2017) -
Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study
por: Oshiro, Hisashi, et al.
Publicado: (2016) -
Diagnostic accuracy and value of chromosomal microarray analysis for chromosomal abnormalities in prenatal detection: A prospective clinical study
por: Huang, Hailong, et al.
Publicado: (2021) -
A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation
por: Xiang, Xuebao, et al.
Publicado: (2022)